3D imaging reveals divergent effects of two cancer drugs
A transparent 3D Cell Painting method revealed that two cancer drugs with similar effects in flat cultures diverged inside minispheres ...
A transparent 3D Cell Painting method revealed that two cancer drugs with similar effects in flat cultures diverged inside minispheres ...
New research shows that triple-negative breast cancer cells rely on shared DNA damage tolerance enzymes such as POLζ and CHK1 ...
Researchers combined anti-PD-L1 immunotherapy with the PARP inhibitor Olaparib to trigger ferroptosis in liver cancer and used the SLC7A11-targeted PET ...
A Phase 1 trial found that combining the ATR inhibitor ceralasertib with the PARP inhibitor olaparib was generally well tolerated ...
A real-world study of 214 patients finds that adding Bevacizumab to Olaparib maintenance therapy significantly improves overall survival only in ...
We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.
Bioengineer.org Ā© Copyright 2023 All Rights Reserved.
Bioengineer.org Ā© Copyright 2023 All Rights Reserved.